Paul Silva, Director at Rapport Therapeutics, Inc., holds 3.68K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 10.05K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds ― shares in Nurix Therapeutics (Ticker: NRIX). Most recently, Paul Silva Bought ― shares of Rapport Therapeutics, Inc. on Oct 22, 2026 for an estimated value of $99.62K.
What is the percentage of profitable transactions made by Paul Silva?
The percentage of profitable transactions made by Paul Silva is ―.
What is the average return per transaction made by Paul Silva?
The average return per transaction made by Paul Silva is ―.
What stocks does Paul Silva hold?
Paul Silva holds: RAPP, VRTX, NRIX stocks.
What was Paul Silva’s latest transaction?
Paul Silva latest transaction was an Informative Buy of $99.62K.
What was Paul Silva's most profitable transaction?
Paul Silva’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul Silva's role in Rapport Therapeutics, Inc.?
Paul Silva's role in Rapport Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.